Because of the diverse etiologies of community-acquired pneumonia (CAP) and the
limitations of current diagnostic modalities, serum procalcitonin levels have been proposed …

Community-acquired pneumonia (CAP) is the prominent cause of mortality and morbidity
with important clinical impact across the globe. India accounts for 23 per cent of global …

Although pneumonia caused by SARS-CoV-2 is a prominent feature of COVID-19, clinicians
must consider whether treatment for additional potential causes of community-acquired …

Since the first cases in December 2019, the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) has rapidly spread across the globe, resulting in the COVID-19 pandemic …

Introduction Procalcitonin expression is thought to be stimulated by bacteria and suppressed
by viruses via interferon signalling. Consequently, during respiratory viral illness, clinicians …

While deep learning has shown promise in improving the automated diagnosis of disease
based on chest X-rays, deep networks may exhibit undesirable behavior related to short …

Community-acquired pneumonia (CAP) is one of the respiratory infectious diseases caused
by not only bacteria, but also viruses. Antibiotic agents are needed to treat only bacterial but …

Background: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has affected millions of individuals since December …

Staphylococcus aureus is an emergent etiology of community-acquired pneumonia (CAP)
over the past 2 decades, with severe community-acquired pneumonia (SCAP) caused by …

Background Biomarkers such as C‐reactive protein (CRP) and procalcitonin may help
distinguish community‐acquired pneumonia (CAP) from other causes of lower respiratory …